Last edition
News about "febrile neutropenia"
US FDA Approves Accord BioPharma's ENNUMO Pegfilgrastim Biosimilar
The US Food and Drug Administration (FDA) has approved Accord BioPharma’s ENNUMO (pegfilgrastim-pccg), expanding its US biosimilar portfolio and strengthening access to G-CSF therapies for cancer patients.
Febrile Neutropenia | 10/07/2026 | By News Bureau
Bora Biologics Partners with Cipla Subsidiary to Manufacture NYPOZI at San Diego Facility
Bora Biologics has partnered with InvaGen Pharmaceuticals, a wholly owned subsidiary of Cipla Ltd., for the manufacture of NYPOZI at its FDA-registered facility in San Diego, California.
Febrile Neutropenia | 29/09/2025 | By Dineshwori | 357
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy